Commercial Pharmaceutical Analytics Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2032
Commercial pharmaceutical
analytics is the use of analytical software to manage and analyze biological
and biomedical data from life science industries like hospitals, laboratories,
and pharmaceutical companies. It helps to improve the efficiency and
effectiveness of pharmaceutical research and development, marketing, and sales.
The commercial
pharmaceutical analytics market is expected to grow at a CAGR of 18.90%
from 2023 to 2032. The growth of the market is driven by the increasing demand
for new drugs and therapies, the need to improve the efficiency of drug
development, and the increasing use of data analytics in the pharmaceutical
industry.
The key players in the
commercial pharmaceutical analytics market are:
- IBM
- SAS Institute
- Oracle
- Microsoft
- SAP
- 3M
- IQVIA
- ICON plc
- PAREXEL International Corporation
- Bristol-Myers Squibb Company
- Pfizer Inc.
These companies are
developing and providing commercial pharmaceutical analytics solutions to
pharmaceutical companies, CROs, and academic institutions.
The key drivers of the
commercial pharmaceutical analytics market Insights are:
- Increasing demand for new drugs and therapies:
The global pharmaceutical market is growing rapidly, driven by the
increasing prevalence of chronic diseases and the need for new and
innovative treatments. This is driving the demand for commercial
pharmaceutical analytics, which can be used to identify new drug targets,
develop new drug formulations, and optimize drug development processes.
- Need to improve the efficiency of drug
development: The drug development process is long and expensive, and it
can take many years to bring a new drug to market. Commercial
pharmaceutical analytics can be used to improve the efficiency of drug
development by identifying potential drug targets, optimizing drug
formulations, and predicting drug safety and efficacy.
- Increasing use of data analytics in the
pharmaceutical industry: The pharmaceutical industry is increasingly using
data analytics to improve decision-making. Commercial pharmaceutical
analytics can be used to analyze data from clinical trials, market
research, and sales data to make better decisions about drug development,
marketing, and sales.
The commercial pharmaceutical
analytics market is segmented by:
- Component: Software, services, and hardware.
- Application: Drug discovery, clinical trials,
marketing, and sales.
- End-user: Pharmaceutical companies, contract
research organizations (CROs), and academic institutions.
- Region: North America, Europe, Asia-Pacific,
and Latin America.
The software segment is the
largest segment of the commercial pharmaceutical analytics market, followed by
the services segment. The software segment is expected to grow at the highest
CAGR during the forecast period, due to the increasing demand for new and
innovative software solutions for drug discovery, clinical trials, marketing,
and sales.
The North America region is
the largest market for commercial pharmaceutical analytics, followed by Europe
and Asia-Pacific. The North America region is expected to continue to be the
largest market during the forecast period, due to the presence of a large
number of pharmaceutical companies and CROs in the region.
About US:
Market Research Future (MRFR) enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment